Elise Wouters
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Functional Humoral Response During Intranasal Convalescent Plasma Prophylaxis for Severe Acute Respiratory Syndrome Coronavirus 2.
Journal: The Journal of infectious diseases
Published: January 24, 2025
Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma.
Journal: Scientific reports
Published: September 23, 2024
Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters.
Journal: EBioMedicine
Published: February 09, 2023
Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders.
Journal: Frontiers in pharmacology
Published: October 20, 2022
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: July 09, 2021
Discovery of a true bivalent dopamine D2 receptor agonist.
Journal: European journal of medicinal chemistry
Published: September 16, 2020
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
Journal: Biochemical pharmacology
Published: December 22, 2019
Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor-Receptor Interaction in a Model of Movement Disorders.
Journal: Frontiers in pharmacology
Published: December 13, 2019
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds.
Journal: ACS pharmacology & translational science
Published: September 03, 2019
Last Updated: 09/26/2026